JAPAN PURE CHEMICAL (4973) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Although revenue growth was substantial at 21.9%, operating income growth remained at just 4.8%, making the fact that revenue growth has not translated sufficiently into profit growth the most important point this period. Revenue was ¥12.27B (+21.9% year on year), operating income was ¥0.44B (+4.8%), ordinary income was ¥0.62B (+10.1%), and net income was ¥1.43B (+7.7%). The decline in the operating margin resulting from the persistently high cost ratio was offset by non-operating and extraordinary income, including dividend income and a ¥1.35B gain on the sale of investment securities. Consequently, temporary factors made a substantial contribution to net income growth.

Factors Affecting Performance

【Revenue】Revenue increased 21.9% year on year to ¥12.27B. Although segment information has not been disclosed, the expansion of sales volume in the chemical manufacturing business appears to have been the primary factor.

【Profit and Loss】Operating income remained at ¥0.44B (+4.8%), and the operating margin declined to 3.6% from approximately 4.1% in the previous year. The cause was the persistently high cost of sales ratio of 88.3%, indicating that revenue growth has not led to an improvement in operating leverage. Ordinary income was ¥0.62B (+10.1%), supported primarily by non-operating income, including ¥0.19B in dividend income. Net income was ¥1.43B (+7.7%), but the temporary factor of a ¥1.35B gain on the sale of investment securities accounted for 94% of net income, requiring it to be evaluated separately from recurring earnings power. In conclusion, although this earnings period represented higher revenue and higher profit, it should be characterized as low-quality earnings growth accompanied by a decline in profitability at the operating level.

Key Financial Indicators

【Profitability】The operating margin was 3.6%, the ordinary income margin was 5.1%, and the net profit margin was 11.7%. The high net profit margin was substantially boosted by the ¥1.35B gain on the sale of investment securities, while the underlying earnings power of the core business is reflected in the 3.6% operating margin. The company has a high-cost structure, with a gross margin of 11.7% and a cost ratio of 88.3%.【Cash Flow Quality】The gain on the sale of investment securities accounted for 94% of net income of ¥1.43B, creating a substantial gap with operating income of ¥0.44B and ordinary income of ¥0.62B. It should therefore be noted that earnings quality appears higher than the recurring level.【Investment Efficiency】ROE was 8.6%, decomposed into a net profit margin of 11.7% × total asset turnover of 0.62x × financial leverage of 1.18x. Investment securities accounted for 47.2% of total assets, suppressing asset turnover, while ROIC remained at 4.4%.【Financial Soundness】The company has an extremely conservative financial structure, with an equity ratio of 84.5%, a current ratio of 2,038.5%, and a debt-to-equity ratio of 0.18x. Cash and deposits of ¥7.14B substantially exceeded short-term liabilities of ¥0.49B.

Cash Flow Analysis

Although a statement of cash flows has not been disclosed, an examination of the company’s funding position based on balance-sheet trends shows that cash and deposits declined from ¥7.59B in the previous year to ¥7.14B, while investment securities increased from ¥5.97B to ¥9.31B, suggesting that surplus funds were directed toward investment securities. Net assets increased by ¥3.07B, from ¥13.59B to ¥16.66B, with the increase in valuation difference on available-for-sale securities contributing in addition to the accumulation of retained earnings. Cash and deposits were approximately 14.4 times current liabilities of ¥0.49B, indicating substantial short-term liquidity. Since a ¥1.35B gain on the sale of investment securities was recorded as extraordinary income, the company appears to have realized gains through the partial sale of its securities holdings during the period, suggesting that its asset composition may have undergone rebalancing.

Earnings Quality

Net income of ¥1.43B substantially exceeded ordinary income of ¥0.62B, with the primary cause of this difference being the temporary extraordinary gain of ¥1.35B on the sale of investment securities. Non-operating income of ¥0.20B also consisted primarily of ¥0.19B in dividend income. As this represents returns from financial assets held rather than income generated by business activities themselves, ordinary income also includes a contribution from non-business-related income. Accordingly, operating income of ¥0.44B (operating margin of 3.6%) should be used as the basis for assessing the company’s underlying business performance. It is appropriate to interpret the net profit margin of 11.7% and ROE of 8.6% as having been inflated by temporary factors. No extraordinary losses were recorded, limiting downside factors for earnings; however, from an accrual perspective, it should be noted that gains from the sale of securities at the same level may not continue from the next fiscal year onward.

Earnings Forecast and Guidance

The full-year forecast is revenue of ¥17.50B (+25.0%), operating income of ¥0.54B (+5.9%), ordinary income of ¥0.73B (+9.0%), and net income of ¥1.75B (+20.7%). The Q3 cumulative progress rates are 70.1% for revenue, 80.9% for operating income, 84.9% for ordinary income, and 81.9% for net income. Operating income and ordinary income are ahead of the standard 75% progress benchmark. Revenue progress, however, is somewhat behind schedule, requiring approximately ¥5.23B of revenue in Q4. The full-year forecast assumes an operating margin of 3.1%, below the Q3 cumulative margin of 3.6%, and is notable for incorporating a decline in profitability toward the second half of the fiscal year.

Shareholder Returns

The Q2 dividend was ¥63.00 per share, while the full-year dividend forecast is ¥200.00. Based on forecast full-year EPS of ¥302.43, the forecast payout ratio is 66.1%, slightly above the general benchmark of 60%. Financial capacity, including cash and deposits of ¥7.14B, an equity ratio of 84.5%, and a current ratio of 2,038.5%, supports the safety of dividend payments. However, as the core operating margin of 3.6% and ROIC of 4.4% are low, the sustainability of shareholder returns depends not on gains from the sale of investment securities but on stable growth in operating income and ordinary income.

Risk Factors

1. Vulnerability of the earnings structure: The company has low margins, with a gross margin of 11.7% and an operating margin of 3.6%, making it susceptible to fluctuations in raw-material costs and selling prices. The EBIT margin is below 5%.

2. Non-recurring nature of earnings: The ¥1.35B gain on the sale of investment securities accounted for ¥1.35B of net income of ¥1.43B, limiting the reproducibility of recurring earnings power. ROE of 8.6% has also been boosted by temporary gains.

3. Asset concentration risk: Investment securities of ¥9.31B accounted for 47.2% of total assets, and fluctuations in market prices could affect valuation differences, net assets, and deferred tax liabilities of ¥2.34B.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Growth and Capital Efficiency

※Source: Compiled by the Company

Key Points from the Earnings Results

1. Revenue growth of +21.9% year on year substantially exceeded the industry median, while the operating margin declined to 3.6%. The fact that revenue growth did not lead to an improvement in profitability is a key point in the earnings results.

2. Net income of ¥1.43B included a ¥1.35B gain on the sale of investment securities. In evaluating the full-year progress rate, it is therefore necessary to focus primarily on operating income (80.9%) and ordinary income (84.9%).

3. The financial foundation is extremely strong, with an equity ratio of 84.5% and a current ratio of 2,038.5%. However, investment securities account for 47.2% of total assets, making improvement in the core business’s capital efficiency (ROIC of 4.4%) a key focus going forward.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,320–¥2,450 at cost of equity ±1%; ¥2,369–¥2,393 at ω±0.1.

Notes:

• Normalized EPS calculated from ordinary income and other figures is used to exclude the impact of temporary gains and losses (company forecast EPS is ¥302.4).
• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility and, where necessary, after consulting with a professional advisor.

---End of Report---